Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 172 articles:
HTML format
Text format



Single Articles


    November 2017
  1. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    October 2017
  2. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  3. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  4. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  5. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  6. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed     Text format    


  7. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  8. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  9. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  10. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  11. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  12. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  13. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  14. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  15. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed     Text format    


  16. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  17. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  18. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    August 2017
  19. SIN DD, Leung JM, Wechsler ME
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  20. TOMMOLA M, Ilmarinen P, Tuomisto LE, Kankaanranta H, et al
    Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  21. BATEMAN ED, Guerreros AG, Brockhaus F, Holzhauer B, et al
    Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  22. PRETOLANI M, Soussan D, Poirier I, Thabut G, et al
    Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  23. ERJ August Podcast: Fevipiprant in allergic asthma not controlled by low-dose inhaled corticosteroids.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  24. MICHILS A, Haccuria A, Michiels S, Van Muylem A, et al
    Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  25. THOMSON NC, Chanez P
    How effective is bronchial thermoplasty for severe asthma in clinical practice?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  26. CHUPP G, Laviolette M, Cohn L, McEvoy C, et al
    Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    July 2017
  27. COTTIN V
    Combined pulmonary fibrosis and emphysema: bad and ugly all the same?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  28. JACOB J, Bartholmai BJ, Rajagopalan S, Kokosi M, et al
    Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    June 2017
  29. CARPAIJ OA, Nieuwenhuis MAE, Koppelman GH, van den Berge M, et al
    Childhood factors associated with complete and clinical asthma remission at 25 and 49 years.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  30. MARTINEZ-GARCIA MA, Maiz-Carro L
    The challenge of defining exacerbation in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  31. HILL AT, Haworth CS, Aliberti S, Barker A, et al
    Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  32. "The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts." Louise Fleming, Clare Murray, Aruna T. Bansal, Simone Hashimoto, Hans Bisgaard, Andrew Bush, Urs Frey, Gunilla Hedlin, Florian Singer, Wim M. va
    Eur Respir J. 2017;49.
    PubMed     Text format    



  33. "Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort." Dominick E. Shaw, Ana R. Sousa, Stephen J. Fowler, Louise J. Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T. Bansal, Elisabeth H. Bel,
    Eur Respir J. 2017;49.
    PubMed     Text format    


  34. AL SALLAKH MA, Vasileiou E, Rodgers SE, Lyons RA, et al
    Defining asthma and assessing asthma outcomes using electronic health record data: a systematic scoping review.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  35. DUNICAN EM, Fahy JV
    Asthma and corticosteroids: time for a more precise approach to treatment.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  36. BERTHON BS, Gibson PG, Wood LG, MacDonald-Wicks LK, et al
    A sputum gene expression signature predicts oral corticosteroid response in asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  37. BUHL R, Humbert M, Bjermer L, Chanez P, et al
    Severe eosinophilic asthma: a roadmap to consensus.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  38. MIRAVITLLES M
    Diagnosis of asthma-COPD overlap: the five commandments.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  39. BOUSQUET J, Chavannes NH, Guldemond N, Haahtela T, et al
    Realising the potential of mHealth to improve asthma and allergy care: how to shape the future.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  40. MCDONALD VM, Gibson PG
    "To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  41. HIMES BE, Ortega VE
    Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  42. HERBERT C, Kumar RK
    Ambient air pollution and asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  43. MIRAVITLLES M, Alvarez-Gutierrez FJ, Calle M, Casanova C, et al
    Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  44. EDWARDS MR, Saglani S, Schwarze J, Skevaki C, et al
    Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  45. COSIO BG, Perez de Llano L, Lopez Vina A, Torrego A, et al
    Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  46. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  47. MASEFIELD S, Edwards J, Hansen K, Hamerlijnck D, et al
    The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP).
    Eur Respir J. 2017;49.
    PubMed     Text format    


  48. PAPADOPOULOS NG, Androutsopoulou A, Akdis C, Dahlen SE, et al
    Asthma research in Europe: a transformative agenda for innovation and competitiveness.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  49. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  50. THOMSON NC
    Asthma and smoking-induced airway disease without spirometric COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  51. AZAD MB, Vehling L, Lu Z, Dai D, et al
    Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  52. BONTEN TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, et al
    Defining asthma-COPD overlap syndrome: a population-based study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  53. SIMPSON AJ, Honkoop PJ, Kennington E, Snoeck-Stroband JB, et al
    Perspectives of patients and healthcare professionals on mHealth for asthma self-management.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  54. BERAIR R, Hartley R, Mistry V, Sheshadri A, et al
    Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  55. YAN Q, Brehm J, Pino-Yanes M, Forno E, et al
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  56. HTET TD, Teede HJ, de Courten B, Loxton D, et al
    Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  57. OLVEIRA C, Martinez-Garcia MA
    Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  58. SPINOU A, Siegert RJ, Guan WJ, Patel AS, et al
    The development and validation of the Bronchiectasis Health Questionnaire.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  59. AAMLI GAGNAT A, Gjerdevik M, Gallefoss F, Coxson HO, et al
    Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    April 2017
  60. VALLIERES E, Tumelty K, Tunney MM, Hannah R, et al
    Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  61. HILLIAM Y, Moore MP, Lamont IL, Bilton D, et al
    Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  62. FRIJA-MASSON J, Martin C, Regard L, Lothe MN, et al
    Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  63. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  64. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  65. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  66. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  67. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  68. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  69. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  70. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  71. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  72. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  73. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  74. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  75. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  76. BAHMER T, Waschki B, Schatz F, Herzmann C, et al
    Physical activity, airway resistance and small airway dysfunction in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  77. DE-TORRES JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, et al
    Telomere length, COPD and emphysema as risk factors for lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  78. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  79. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  80. ERJ January Podcast: the BioSHaRE approach to understanding of the effects of air pollution on asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  81. ALIBERTI S, Dhar R, Aksamit TR, Morgan L, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  82. GUAN WJ, Gao YH, Yuan JJ, Chen RC, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    December 2016
  83. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  84. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  85. SHIN S, Park HY, Kim H, Kim HK, et al
    Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01148-2016. doi: 10.1183/13993003.01148-2016.
    PubMed     Text format     Abstract available


  86. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  87. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  88. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  89. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


    October 2016
  90. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  91. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  92. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  93. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  94. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  95. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  96. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  97. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  98. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  99. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  100. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available



  101. ERJ September Podcast: research priorities in bronchiectasis.
    Eur Respir J. 2016;48:E69.
    PubMed     Text format    


  102. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  103. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  104. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  105. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  106. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  107. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  108. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  109. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  110. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  111. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  112. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    



  113. "Tidal flow variability measured by impedance pneumography relates to childhood asthma risk." Ville-Pekka Seppa, Anna S. Pelkonen, Anne Kotaniemi-Syrjanen, Jari Viik, Mika J. Makela and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687-1696.
    Eur Respir J. 2016;48:285.
    PubMed     Text format    


    June 2016
  114. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  115. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  116. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  117. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    


  118. ALIBERTI S, Masefield S, Polverino E, De Soyza A, et al
    Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.
    Eur Respir J. 2016 Jun 10. pii: ERJ-01888-2015. doi: 10.1183/13993003.01888-2015
    PubMed     Text format     Abstract available



  119. "Asthma inhaler adherence determinants in adults: systematic review of observational data." Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994-1018.
    Eur Respir J. 2016;47:1892.
    PubMed     Text format    


  120. SORIANO JB, Serrano J
    Bronchiectasthma and asthmectasis!
    Eur Respir J. 2016;47:1597-600.
    PubMed     Text format    


    May 2016
  121. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  122. SUBRAMANIAN DR, Gupta S, Burggraf D, Vom Silberberg SJ, et al
    Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Eur Respir J. 2016 May 26. pii: ERJ-01878-2015. doi: 10.1183/13993003.01878-2015
    PubMed     Text format     Abstract available


  123. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  124. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  125. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


  126. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


    April 2016
  127. LUM S, Stocks J
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1292-3.
    PubMed     Text format    


  128. HULS A, Kramer U, Schuster A, Gappa M, et al
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1290-2.
    PubMed     Text format    


  129. GOMEZ C, Chanez P
    The lung microbiome: the perfect culprit for COPD exacerbations?
    Eur Respir J. 2016;47:1034-6.
    PubMed     Text format    


  130. BOUSQUET J, Barbara C, Bateman E, Bel E, et al
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
    Eur Respir J. 2016;47:1028-33.
    PubMed     Text format    


  131. SPRUIT MA, Franssen FM, Rutten EP, Wopereis S, et al
    A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.
    Eur Respir J. 2016;47:1024-7.
    PubMed     Text format    


  132. COSTA C, Traves SL, Tudhope SJ, Fenwick PS, et al
    Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD.
    Eur Respir J. 2016;47:1093-102.
    PubMed     Text format     Abstract available


  133. CHARUSUSIN N, Gosselink R, McConnell A, Demeyer H, et al
    Inspiratory muscle training improves breathing pattern during exercise in COPD patients.
    Eur Respir J. 2016;47:1261-4.
    PubMed     Text format    


  134. WANG Z, Bafadhel M, Haldar K, Spivak A, et al
    Lung microbiome dynamics in COPD exacerbations.
    Eur Respir J. 2016;47:1082-92.
    PubMed     Text format     Abstract available


  135. DIZIER MH, Nadif R, Margaritte-Jeannin P, Barton SJ, et al
    Interaction between the DNAH9 gene and early smoke exposure in bronchial hyperresponsiveness.
    Eur Respir J. 2016;47:1072-81.
    PubMed     Text format     Abstract available


  136. MUMBY S, Saito J, Adcock IM, Chung KF, et al
    Decreased breath excretion of redox active iron in COPD: a protective failure?
    Eur Respir J. 2016;47:1267-70.
    PubMed     Text format    


    March 2016
  137. KOLAHIAN S, Oz HH, Zhou B, Griessinger CM, et al
    The emerging role of myeloid-derived suppressor cells in lung diseases.
    Eur Respir J. 2016;47:967-77.
    PubMed     Text format     Abstract available


  138. BARTOLI ML, Costa F, Malagrino L, Nieri D, et al
    Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines.
    Eur Respir J. 2016;47:978-80.
    PubMed     Text format    


  139. ZAIGHAM S, Wollmer P, Engstrom G
    Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Eur Respir J. 2016;47:742-50.
    PubMed     Text format     Abstract available


    February 2016
  140. BOLAND AC, Hodgekiss C, Hicks F, Edwards A, et al
    Improving end-of-life communication between primary and secondary care within respiratory medicine.
    Eur Respir J. 2016;47:658-60.
    PubMed     Text format    


  141. MOSS RB
    Treating allergic bronchopulmonary aspergillosis: the way forward.
    Eur Respir J. 2016;47:385-7.
    PubMed     Text format    


  142. SORIANO JB, Suissa S
    Ageing lungs and very elderly COPD: anytime and anywhere.
    Eur Respir J. 2016;47:379-81.
    PubMed     Text format    


  143. LANKEIT M, Held M
    Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
    Eur Respir J. 2016;47:369-73.
    PubMed     Text format    


  144. AGUSTI A, Bel E, Thomas M, Vogelmeier C, et al
    Treatable traits: toward precision medicine of chronic airway diseases.
    Eur Respir J. 2016;47:410-9.
    PubMed     Text format     Abstract available


  145. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  146. MIRAVITLLES M, Vogelmeier C, Roche N, Halpin D, et al
    A review of national guidelines for management of COPD in Europe.
    Eur Respir J. 2016;47:625-37.
    PubMed     Text format     Abstract available


  147. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


  148. LUOTO JA, Elmstahl S, Wollmer P, Pihlsgard M, et al
    Incidence of airflow limitation in subjects 65-100 years of age.
    Eur Respir J. 2016;47:461-72.
    PubMed     Text format     Abstract available


  149. BORVIK T, Braekkan SK, Enga K, Schirmer H, et al
    COPD and risk of venous thromboembolism and mortality in a general population.
    Eur Respir J. 2016;47:473-81.
    PubMed     Text format     Abstract available


  150. MAGNUSSEN H, Tetzlaff K, Bateman ED, Watz H, et al
    Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Eur Respir J. 2016;47:651-4.
    PubMed     Text format    


  151. GARDEN FL, Simpson JM, Mellis CM, Marks GB, et al
    Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis.
    Eur Respir J. 2016;47:499-509.
    PubMed     Text format     Abstract available


    January 2016
  152. ELLIOTT L, von Essen S
    COPD in farmers: what have we learnt?
    Eur Respir J. 2016;47:16-8.
    PubMed     Text format    


  153. SANSORES RH, Ramirez-Venegas A
    COPD in women: susceptibility or vulnerability?
    Eur Respir J. 2016;47:19-22.
    PubMed     Text format    


  154. WELTE T
    Acute exacerbation in COPD: we must do more.
    Eur Respir J. 2016;47:14-5.
    PubMed     Text format    


  155. LAHOUSSE L, Moyse E, Krantic S, Brusselle GG, et al
    Understanding age-related diseases: report of the 2015 Ageing Summit.
    Eur Respir J. 2016;47:5-9.
    PubMed     Text format    


  156. SHAHEEN SO, Macdonald-Wallis C, Lawlor DA, Henderson AJ, et al
    Hypertensive disorders of pregnancy, respiratory outcomes and atopy in childhood.
    Eur Respir J. 2016;47:156-65.
    PubMed     Text format     Abstract available


  157. HARTL S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, et al
    Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.
    Eur Respir J. 2016;47:113-21.
    PubMed     Text format     Abstract available


  158. GUILLIEN A, Puyraveau M, Soumagne T, Guillot S, et al
    Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study.
    Eur Respir J. 2016;47:95-103.
    PubMed     Text format     Abstract available


  159. CURROW DC, Abernethy AP, Allcroft P, Banzett RB, et al
    The need to research refractory breathlessness.
    Eur Respir J. 2016;47:342-3.
    PubMed     Text format    


  160. LEAHY TR, McManus R, Doherty DG, Grealy R, et al
    Interleukin-15 is associated with disease severity in viral bronchiolitis.
    Eur Respir J. 2016;47:212-22.
    PubMed     Text format     Abstract available


  161. LAZAR Z, Mullner N, Lucattelli M, Ayata CK, et al
    NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Eur Respir J. 2016;47:254-63.
    PubMed     Text format     Abstract available


  162. MOTTE S, Melot C, Di Pierdomenico L, Martins D, et al
    Predictors of costs from the hospital perspective of primary pulmonary embolism.
    Eur Respir J. 2016;47:203-11.
    PubMed     Text format     Abstract available


  163. RADEMACHER J, Schulz A, Hedtfeld S, Stanke F, et al
    Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2016;47:322-4.
    PubMed     Text format    


  164. GABROVSKA M, Lacombe E, Bruyneel M, Ninane V, et al
    Acute bronchospasm during passive exposure to bronchial provocation tests.
    Eur Respir J. 2016;47:320-2.
    PubMed     Text format    


  165. YANG JY, Oh SY, Song JW, Shim TS, et al
    Restrictive chronic lung function decline after haematopoietic stem cell transplantation.
    Eur Respir J. 2016;47:336-9.
    PubMed     Text format    


  166. SUISSA S
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:354-5.
    PubMed     Text format    


  167. LETTIS S, Keene O
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:353-4.
    PubMed     Text format    


    December 2015
  168. POPOVIC M, Rusconi F, Zugna D, Galassi C, et al
    Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00315-2015. doi: 10.1183/13993003.00315-2015.
    PubMed     Text format     Abstract available


    October 2015
  169. COX DW, Mullane D, Zhang GC, Turner SW, et al
    Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00397-2015. doi: 10.1183/13993003.00397-2015
    PubMed     Text format     Abstract available


  170. YAMMINE S, Schmidt A, Sutter O, Fouzas S, et al
    Functional evidence for continued alveolarisation in former preterms at school age?
    Eur Respir J. 2015 Oct 22. pii: ERJ-00478-2015. doi: 10.1183/13993003.00478-2015
    PubMed     Text format     Abstract available


    August 2015
  171. MCKEON NJ, Timmins SN, Stewart H, Yerkovich ST, et al
    Diagnosis of COPD before cardiac surgery.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02339-2014. doi: 10.1183/13993003.02339-2014
    PubMed     Text format    


    July 2015
  172. GAUVREAU GM, El-Gammal AI, O'Byrne PM
    Allergen-induced airway responses.
    Eur Respir J. 2015 Jul 23. pii: ERJ-00536-2015. doi: 10.1183/13993003.00536-2015
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: